ArticleBMC pregnancy and childbirth2026
Does the recovery of serum FSH influence the ovarian sensitivity index in the follicular-phase depot GnRH agonist protocol?
Article in BMC pregnancy and childbirth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundThe follicular-phase long GnRHa protocol is a common protocol in COH. This study mainly analyzed the recovery of FSH levels on the day of Gn initiation compared with basal FSH levels on the day of downregulation and studied the correlation with the OSI to discover a new monitoring target for COH.
methodsA total of 2286 patients who underwent IVF/ICSI with the follicular-phase depot GnRH agonist protocol from January 2018 to January 2023 were stratified into cohorts. The primary outcome was the OSI in patients who received the follicular-phase depot GnRH agonist protocol. The GnFSH/bFSH ratio was used to represent FSH recovery. The enrolled patients were divided into 3 groups according to GnFSH/bFSH tertiles, and cycle characteristics and outcomes were compared. The relationship between the GnFSH/bFSH ratio and OSI was analyzed using smoothed curve fitting to determine the threshold or saturation point for the study population. Then, the relationship between the GnFSH/bFSH and OSI was tested with a multivariable linear regression model after adjusting for potential confounders. RESULT(S): After adjusting for potential confounders, when the GnFSH/bFSH ratio was less than 0.8, the OSI increased with increasing GnFSH/bFSH values (β = 2.96, 95% CI = 2.37, 3.56, P < 0.0001). However, there was no significant relationship between GnFSH/bFSH and OSI values when the ratio was higher than 0.8 (β = 0.19, 95% CI= -2.02, 2.39, P = 0.8686). In the multiple linear regression model, after full adjustment, each one-unit increase in the GnFSH/bFSH value was related to increased OSI values (β = 2.59, 95% CI 2.10, 3.09, P < 0.0001). In GnFSH/bFSH tertile groups, patients in T2 (0.37-0.56) and T3 (> 0.56) had increased OSI values (β = 0.49, 95% CI 0.24, 0.74, P = 0.0001 and β = 1.25, 95% CI 0.99, 1.51, P < 0.0001, respectively) when compared with patients with values in T1 (< 0.37). CONCLUSION(S): The recovery of serum FSH (GnFSH/bFSH) after pituitary suppression is an independent risk factor for increased OSI values in women undergoing the follicular-phase depot GnRH agonist protocol.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.